| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.0M | -71.0% |
| R&D Expense | $130.2M | +16.1% |
| SG&A Expense | $46.5M | +20.8% |
| Operating Income | -$166.6M | -43.6% |
| Pre-tax Income | -$149.1M | -46.4% |
| Income Tax | -$9K | -104.7% |
| Net Income | -$149.1M | -46.1% |
| EPS (Basic) | -$1.65 | -19.6% |
| EPS (Diluted) | -$1.65 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.3M | -68.2% |
| Accounts Receivable | $265K | +79.1% |
| Current Assets | $219.4M | -35.3% |
| Total Assets | $313.3M | -27.5% |
| Current Liabilities | $30.7M | +8.3% |
| Total Liabilities | $60.4M | -5.4% |
| Stockholders' Equity | $253.0M | -31.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$138.2M | -48.1% |
| Capital Expenditures | $4.9M | -58.0% |
| Investing Cash Flow | $86.6M | +227.0% |
| Financing Cash Flow | $16.7M | -89.2% |
| Free Cash Flow | -$143.1M | -36.4% |
| -19.6% |